Latest articlesAll articles
Congress reviewsAll congress reviews
EAU Congress Interview: Arnulf Stenzl
A large part of urology is uro-oncology, so let’s start here. We have seen a minimalisation of surgery, so we are doing more robotic surgery and are trying to preserve more organs. For example, in renal cell cancer, we try to spare the kidney if possible and be minimally invasive.
Latest InfographicsAll Infographics
Latest NewsAll News
Latest PodcastsAll Podcasts
23rd October 2023
A podcast exploring the DaBlaCa-13 study, chemoresection with dose-dense mitomycin C (MMC) in patients with recurrent non-muscle-invasive bladder cancer (intermediate-risk)
Tune in for a fascinating discussion with Jørgen Bjerggaard Jensen, as he explores recent breakthroughs in non-muscle-invasive bladder cancer management through mitomycin C (MMC) chemoresection.